Bowhead Specialty Holdings Inc. (NYSE:BOW - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $39.67.
A number of analysts recently weighed in on the company. Keefe, Bruyette & Woods boosted their target price on Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a research report on Friday, May 9th. JPMorgan Chase & Co. boosted their price objective on shares of Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a report on Tuesday, April 8th. Morgan Stanley upped their price objective on shares of Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Piper Sandler began coverage on shares of Bowhead Specialty in a research report on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 target price on the stock. Finally, JMP Securities upped their price target on shares of Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a research report on Friday, April 11th.
View Our Latest Stock Report on Bowhead Specialty
Bowhead Specialty Trading Down 0.9%
Shares of NYSE:BOW traded down $0.31 during trading on Monday, reaching $35.15. The company had a trading volume of 106,010 shares, compared to its average volume of 202,844. The company has a fifty day moving average of $37.79 and a two-hundred day moving average of $36.07. The stock has a market capitalization of $1.15 billion, a P/E ratio of 26.83 and a beta of -0.60. Bowhead Specialty has a 12 month low of $24.41 and a 12 month high of $42.29.
Bowhead Specialty (NYSE:BOW - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.01. Bowhead Specialty had a return on equity of 12.52% and a net margin of 9.32%. The business had revenue of $174.85 million for the quarter, compared to the consensus estimate of $105.17 million. As a group, equities research analysts predict that Bowhead Specialty will post 1.36 earnings per share for the current year.
Institutional Trading of Bowhead Specialty
Institutional investors have recently modified their holdings of the company. Goldman Sachs Group Inc. raised its position in Bowhead Specialty by 33.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 121,705 shares of the company's stock valued at $4,947,000 after purchasing an additional 30,440 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of Bowhead Specialty by 34.7% during the first quarter. Rhumbline Advisers now owns 16,973 shares of the company's stock valued at $690,000 after acquiring an additional 4,372 shares in the last quarter. Strs Ohio purchased a new stake in Bowhead Specialty in the first quarter worth $614,000. Voleon Capital Management LP lifted its stake in Bowhead Specialty by 25.9% in the first quarter. Voleon Capital Management LP now owns 193,247 shares of the company's stock worth $7,855,000 after acquiring an additional 39,704 shares during the period. Finally, NewEdge Advisors LLC bought a new stake in Bowhead Specialty in the first quarter valued at $206,000.
Bowhead Specialty Company Profile
(
Get Free ReportBowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.